Breakell, T. (2024). Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis. Friedrich-Alexander-Universität Erlangen-Nürnberg. https://doi.org/10.25593/open-fau-609
Chicago-Zitierstil (17. Ausg.)Breakell, Thomas. Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis. Erlangen ; Nürnberg: Friedrich-Alexander-Universität Erlangen-Nürnberg, 2024. https://doi.org/10.25593/open-fau-609.
MLA-Zitierstil (9. Ausg.)Breakell, Thomas. Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis. Friedrich-Alexander-Universität Erlangen-Nürnberg, 2024. https://doi.org/10.25593/open-fau-609.